1. Home
  2. CXT vs CDNA Comparison

CXT vs CDNA Comparison

Compare CXT & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crane NXT Co.

CXT

Crane NXT Co.

SELL

Current Price

$54.73

Market Cap

2.9B

Sector

Industrials

ML Signal

SELL

Logo CareDx Inc.

CDNA

CareDx Inc.

SELL

Current Price

$65.18

Market Cap

2.6B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CXT
CDNA
Founded
1855
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.6B
IPO Year
1994
2007

Fundamental Metrics

Financial Performance
Metric
CXT
CDNA
Price
$54.73
$65.18
Analyst Decision
Strong Buy
Buy
Analyst Count
7
7
Target Price
★ $68.71
$61.67
AVG Volume (30 Days)
513.8K
★ 1.4M
Earning Date
11-04-2026
10-29-2026
Dividend Yield
★ 1.33%
N/A
EPS Growth
★ N/A
N/A
EPS
0.72
★ 2.13
Revenue
★ $3,374,900,000.00
$48,324,000.00
Revenue This Year
$16.05
$30.36
Revenue Next Year
$6.10
$6.23
P/E Ratio
$75.38
★ $31.29
Revenue Growth
6.13
★ 18.93
52 Week Low
$35.71
$14.03
52 Week High
$68.54
$72.51

Technical Indicators

Market Signals
Indicator
CXT
CDNA
Relative Strength Index (RSI) 69.55 60.23
Support Level $50.25 $61.19
Resistance Level $56.97 $72.51
Average True Range (ATR) 1.62 3.87
MACD 0.76 -0.40
Stochastic Oscillator 93.75 36.89

Price Performance

Historical Comparison
CXT
CDNA

About CXT Crane NXT Co.

Crane NXT Co is a industrial technology company that provides proprietary and trusted technology solutions to secure, detect, and authenticate what matters to its customers. It is a pioneer in proprietary micro-optics technology for securing physical products, and its sophisticated electronic equipment and associated software leverages proprietary core capabilities with detection and sensing technologies. The company operates in two segments which are Crane Payment Innovations (CPI) and Security and Authentication Technologies.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: